Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences Ltd has informed exchanges about a board meeting scheduled for May 29, 2026. The meeting will consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026. Additionally, the board will recommend a final dividend for FY 2025-26, subject to shareholder approval at the ensuing AGM. The company has also stated that the trading window remains closed for designated persons until 48 hours after the financial results are declared. This is a standard regulatory filing with no specific financial numbers or significant disclosures included at this stage.
This is a routine pre-result announcement. The actual impact on the stock will depend on the financial results to be disclosed after the board meeting. Dividend recommendation is typically positive for shareholders if approved.